Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.900
-0.090 (-4.52%)
At close: Mar 31, 2025, 4:00 PM
2.450
+0.550 (28.95%)
After-hours: Mar 31, 2025, 7:59 PM EDT

Compass Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
0.85----
Upgrade
Gross Profit
0.85----
Upgrade
Selling, General & Admin
15.1312.2411.6610.9312.91
Upgrade
Research & Development
42.3438.123020.3414.9
Upgrade
Operating Expenses
57.4850.3641.6631.2627.81
Upgrade
Operating Income
-56.63-50.36-41.66-31.26-27.81
Upgrade
Interest Expense
----0.37-0.91
Upgrade
Interest & Investment Income
7.257.872.360.030.09
Upgrade
Currency Exchange Gain (Loss)
----0
Upgrade
Other Non Operating Income (Expenses)
-----0.56
Upgrade
EBT Excluding Unusual Items
-49.38-42.49-39.3-31.61-29.19
Upgrade
Gain (Loss) on Sale of Assets
--0.070.04-0.28
Upgrade
Pretax Income
-49.38-42.49-39.23-82.18-29.47
Upgrade
Income Tax Expense
----0.03
Upgrade
Net Income
-49.38-42.49-39.23-82.18-29.5
Upgrade
Net Income to Common
-49.38-42.49-39.23-82.18-29.5
Upgrade
Shares Outstanding (Basic)
1371271056331
Upgrade
Shares Outstanding (Diluted)
1371271056331
Upgrade
Shares Change (YoY)
8.15%20.76%67.31%104.28%359.96%
Upgrade
EPS (Basic)
-0.36-0.33-0.37-1.31-0.96
Upgrade
EPS (Diluted)
-0.36-0.33-0.37-1.31-0.96
Upgrade
Free Cash Flow
-44.9-40.65-34.34-21.55-26.91
Upgrade
Free Cash Flow Per Share
-0.33-0.32-0.33-0.34-0.87
Upgrade
Gross Margin
100.00%----
Upgrade
Operating Margin
-6661.76%----
Upgrade
Profit Margin
-5808.82%----
Upgrade
Free Cash Flow Margin
-5282.23%----
Upgrade
EBITDA
-56.04-49.66-40.87-30.7-25.41
Upgrade
D&A For EBITDA
0.590.70.780.572.4
Upgrade
EBIT
-56.63-50.36-41.66-31.26-27.81
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q